Jean-Marie
0000-0003-3482-3331
9 papers found
Refreshing results…
Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review
Repurposing of Anticancer Drugs Expands Possibilities for Antiviral and Anti-Inflammatory Discovery in COVID-19
How to manage patients with corticosteroids in oncology in the era of immunotherapy?
Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors
Organisational factors influencing early clinical trials enrollment: Gustave Roussy experience
Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1
Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials
Consortium de détection et prise en charge des atteintes pulmonaires induites par la bléomycine
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type
Missing publications? Search for publications with a matching author name.